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ABSTRACT Regenerative medicine has a rich and pluralistic history, characterised by a
patchwork of innovation and blind alleys. As scientiﬁc researchers, our understanding of this
hybrid ﬁeld of regeneration in a historical and cultural context is far from complete, in part
due to the range of non-medical contributory disciplines and a fascination with the future
directions of research. This paper explores the different deﬁnitions of regenerative medicine
and highlights issues faced in regenerative medicine research. We argue that a closer rela-
tionship between regenerative medicine and the humanities would enable researchers to
better understand the historical context, ethical implications and public perception of this
rapidly developing ﬁeld. In many cases, this would be through better awareness of the
existing expertise available in humanities research, which is often not visible to those in the
laboratory.
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Introduction
Two of the three authors of this paper are scientiﬁcresearchers working in the ﬁeld of Regenerative Medicine.They have both worked within the Institute of Medical and
Biological Engineering (iMBE) at the University of Leeds, a group
whose research focus is to provide ’50 active years after 50’.
Developments in natural tissue scaffolds, whole joint replace-
ments and better pre-clinical testing strategies are developed to
work towards this goal. For the authors, this has included
working on development of grafts for skin and ligament repair,
development of self-assembling peptides, cell culture, biomaterial
scaffolds and mechanical stimulation of cells. This requires a wide
range of chemical and biological techniques such as chemical
synthesis, microscopy, histology and colourimetric assays to
quantify differences in samples. Yet neither of these authors has
an undergraduate background in biomedical research; one began
in nanotechnology and the other in computer science.
Other members of iMBE come from similar ﬁelds of expertise
in the physical sciences and engineering, working alongside
biologists, biomedical scientists and clinicians. These diverse
backgrounds enable the group to bring to bear different techni-
ques, viewpoints and understandings to complex biological and
biomechanical problems. This may be to model disease states and
treatments, design synthetic or biological replacements, create
new drugs or develop cell based therapies. The interdisciplinary
environment is essential for success in many of these problems.
One problem with this arrangement is that there may be
knowledge gaps in the historical or ethical perspective of practi-
tioners in this ﬁeld. Ethical considerations on the use of human or
animal tissue, animal models and the development of medical
devices may be unfamiliar to those without a biological back-
ground. The authors feel that this range of expertise is
undoubtedly necessary for success in developing new regenerative
medicine therapies, but we need to do more to understand the
wider context of our research. Our ﬁeld needs to draw on
expertise outside of the scientiﬁc laboratory.
Regenerative medicine is a multidisciplinary area of research
and has evolved as an umbrella subject, covering several well-
established ﬁelds, with a diverse range of meanings and impli-
cations. As scientiﬁc researchers working in the ﬁeld, we may
deﬁne regenerative medicine as the application of scientiﬁc
principles to repair, restore, supplement or replace the natural
function of a biological system. We have derived this deﬁnition
from that used by the Medical Research Council (MRC)
“Regenerative medicine is an interdisciplinary approach that
seeks to repair or replace damaged or diseased human cells or
tissues to restore normal function” (MRC, 2017). These deﬁni-
tions are forward facing, trying to address an identiﬁed issue and
meet a clinical need within the scientiﬁc landscape. During the
recent Past, Present and Futures of Medical Regeneration work-
shop series (University of Leeds, 2016), discussions covered the
meaning of regeneration in a wider context. From a biomedical
point of view, the word might suggest the replacement or repair
of a lost or damaged part, or natural processes such as natural
wound healing or asexual reproduction. Discussions suggested
that regeneration, in a generalised sense, may be considered in
terms of renewal, rebirth or restoration. The more general view
expressed in the workshop made us conscious of what is often
missing from the view of modern scientiﬁc researchers compared
with those in the medical humanities.
Until the early 19th or 20th century, scientists were called
natural philosophers and the investigation of the natural world
was regarded as part of the same intellectual sphere as the con-
templation of moral questions or the exploration of conscious-
ness. The great scientiﬁc pioneers of this time associated closely
with others working in different ﬁelds, including what we now
think of as the humanities. Joseph Priestley, credited with the
discovery of oxygen, was also a respected theologian, educationist,
and political commentator, and was minister of Mill Hill Chapel
in Leeds. More recently, scientists like Erwin Schrödinger, a
renowned physicist, proposed theories which have helped us
make great leaps in biology. Schrödinger’s lecture series entitled
‘What is Life?’ was later reproduced as a book and has been
credited with aiding James D. Watson and Francis Crick in their
discovery of the structure of DNA (Derry, 2004). This sort of
close contact between disparate ﬁelds and disciplines is often
missing from modern scientiﬁc research groups.
The phrase ‘regenerative medicine’ ﬁrst appears in the scientiﬁc
consciousness in 1992, where it was used to describe a “new
branch of medicine that will develop, that attempts to change the
course of chronic disease and in many instances will regenerate
tired and failing organ systems” (Kaiser, 1992). Since then, there
has been an exponential increase in the number of journal articles
and research projects identifying themselves as regenerative
medicine. Such projects often seek to repair or replace damaged
or failing organs or tissues to meet a clinical need, extend life or
improve quality of life. Given the long history of medical
research, there was already a vast body of work into improving or
extending human life, which can now be considered as falling into
the area of regenerative medicine.
The ﬁrst recorded examples of reconstructive surgery using
skin grafts were written by Sushruta, dubbed the ‘father of sur-
gery’ in India, in his text the Suśruta-sam
˙
hitā around 750–800 B.
C. In 1869 Jacques-Louis Reverdin would, incorrectly, claim to be
the ﬁrst to report a successful skin graft (Davis, 1941). The evo-
lution of cell biology and a detailed understanding of the struc-
ture and function of skin have led to the development of cell
based therapies for treating skin trauma. Keratinocytes, cells
which form the upper layers of the skin and are responsible for its
important barrier function, were ﬁrst reliably cultured in the
laboratory in 1975 by Rheinwald and Green (Rheinwald and
Green, 1975). This lead to the production of sheets of keratino-
cytes for clinical use in burns victims in the 1980s (O’Connor,
1981, Gallico et al., 1984). Today this approach would be con-
sidered a tissue engineering and regenerative medicine strategy,
and many attempts are being made to further develop and
improve this treatment approach.
Closely linked to regenerative medicine research is the early
work on embryonic development and wound healing in animals.
The work of pioneers like Wilhelm Roux and Hans Driesch in
embryo development investigated how cells responded to damage
during development, which could be considered as the historical
origin of both regeneration and stem cell research. In 1981 the
ﬁrst pluripotent stem cells were isolated and cultured from mouse
embryos, but as far back as the 18th century, descriptions of the
regenerative properties of animals were formulated: Reaumur
detailed the regenerative properties of crustaceans, Spallanzani
studied the regeneration of tadpole tails and Singer observed the
regeneration of limbs in newts (Dinsmore, 2008). The work into
the regrowth of limbs in amphibians is more easily recognised as
the inspiration behind regenerative medicine research and still
forms a large part of current scientiﬁc study.
Challenges in regenerative medicine research
For many early career scientiﬁc researchers in regenerative
medicine, there may have been no formal training in medical
history, ethics or philosophy. Such topics may not be considered
important initially as they are not used directly to inform the
conduct of research immediately post-PhD. This deﬁciency may
be problematic when considering the translation of research from
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bench to bedside. Whilst working in the laboratory, it is easy to
lose sight of how the research will be used in the real world and
how it may be perceived by a non-specialist audience. We argue
that a greater understanding of the research carried out by
humanities scholars would go a long way towards addressing
these gaps in knowledge. To this end, we will here seek to
introduce a range of problems encountered by regenerative
medicine researchers, where the skills of humanities scholars have
the potential to improve scientiﬁc practice.
History. Historically, failure in science was as important as suc-
cess, however in modern research this idea has arguably been lost.
While there is some scope for negative data to be published (such
as The Journal of Negative Results in Biomedicine or Journal of
Articles in Support of the Null Hypothesis), negative or incon-
clusive data generally has a low priority for publication. This
means that there are swathes of relevant research which remains
unpublished due to perceived failure. Although there are efforts
to address this (such as creating data repositories for research
council funded research), it is far from common practice. This
situation has come about due to the dual effect of modern jour-
nals and the increase in incremental directional research funding.
Data which is positive, and so changes our perception of a topic
or conclusively demonstrates a new behaviour, can be published
with relative ease. Negative data, even that which has the same
potential to change perceptions, is often inaccessible to most
researchers. Most concerns regarding the quality and signiﬁcance
of research data focus on rooting out misconduct rather than
questioning the epistemological assumptions of data production
(Hiney, 2015, Martinson et al., 2005). This is not to say that
philosophers and sociologists of science have not identiﬁed these
issues (Knorr-Cetina, 1983, Knorr-Cetina, 1991) but rather that
their insights rarely seem to reach the lab.
The advent of the internet has also created a divide between
recent and historical research. Research published before the rise
of modern electronic journals is signiﬁcantly more difﬁcult to
access than recent publications. This landscape of missing or
incomplete information can lead to the repetition of research
which has already been carried out. It leaves gaps in our
understanding of a process or disease, by reducing the visibility of
proved and disproved hypotheses. In some cases, it makes it
difﬁcult for researchers to access the theory behind a technique
and understand how it may interact with a given sample. A large
amount of research conducted within laboratories is based upon
well-established techniques and protocols. The use of standar-
dised protocols is common in research but also forms a critical
part of the Good Manufacturing Process (GMP), which is
essential for gaining regulatory approval. Standardised protocols
carry their own risks, as they are easy to follow without
understanding their underlying principles. Regenerative medicine
is predominantly focused upon addressing clinical need and
scientiﬁc researchers are always focused upon the next idea,
solution or breakthrough and what this will mean to the future.
This is a symptom of the short-sighted nature of research,
sometimes due to the short-term nature of postdoctoral research
positions. This situation and the attitude that historical research is
less informative shows a kind of arrogance in the modern
researcher, the assumption that the best and most relevant papers
to read are the most recently published. Even among researchers
with an interest in the history of their ﬁeld, this short-sightedness
can in turn lead to a teleological understanding of the ﬁeld’s
development–a ‘presentism’ that imagines said history as a series
of advances towards the standard practice of today–and a failure
to think critically about whether current practice and best
practice are the same thing.
Interacting with medical historians would go a long way
towards addressing this. The perspective offered by medical
historians would allow researchers to better ask if the research has
already been conducted, if there are gaps that modern techniques
can ﬁll in pre-established theory, if explanations to issues faced in
the laboratory have already been discussed, or if a consideration
of historical practices can prompt a reappraisal of current ones. In
laboratory research, there is rarely any doubt that positive results
in the lab will have positive results for patients and society. As
researchers, we would like to believe that this is nearly always
true, but we rarely consider that it might not be. Not only does
this mean that cultural and social issues are not considered, but it
may blinker the research from new avenues or useful methods
from other research areas in a drive to answer a very speciﬁc
research question.
Research developed within the laboratory should, where
possible, be translated into a form which can be used in the
real world to improve the lives of patients. This is an expensive,
complex process which is often unsuccessful. Following basic
development in the laboratory, it is necessary to carry out proof of
concept work, animal studies and develop GMP compliance to
demonstrate the safety and efﬁcacy of the research before the start
of basic clinical trials in humans. New treatments are developed
to treat patients, and it is important that we minimise the side
effects and complications from the treatment. Experimentation
on humans to understand the basic science is considered
unethical, drawing to mind experiments carried out on unwilling
subjects in the past. Medical trials differ from experimentation, as
there is a need to prove the treatment is likely to be safe for
human patients, prior to demonstration of improvement over
existing treatment options. The concepts behind medical trials are
ancient, and the ﬁrst medical trial as we would recognise it today
was conducted in 1747 (published 1753) by James Lind (Hughes,
1975), who tested treatments for scurvy. In 1801 John Haygarth
demonstrated the importance of a control group in medical trials
to account for the placebo effect (Haygarth, 1800). Many of the
concepts and ideas developed historically in medical trials are
now standard practice. Unlike the majority of basic research,
clinical trials are subject not only to scientiﬁc input but also
ethical and cultural considerations. There is a need for them to
address not only the effectiveness and safety of a new treatment,
but the value to society, and whether or not it will be effective
outside of the trial methodology. Many researchers have concerns
about extrapolating from trial data to treat individual patients,
each of whom have a unique set of conditions (Kent and
Hayward, 2007). In some trials, such as those in emergency
medical situations, it may also be difﬁcult to ensure that the
desired protocol is adhered to, reducing the clarity of the ﬁndings
(Sanders, 2011). Clinical trials must consider input from
stakeholders who have different priorities, such as patients,
practitioners, regulatory bodies and industry. Will and Moreira
(2016) discuss the changing role of Randomised Controlled Trials
(RCTs) as an integral part of drug research and development. The
volume discusses the challenges in running RCTs from ﬁnding
suitable methodologies, navigating regulatory constraints and
changing societal views. As part of this, they explore inherent bias
in reporting; if a drug does not have the desired effect, this may
not be reported, leading to missing information and future waste
in resources on similar drugs. In other cases, trials may show
beneﬁts of the control treatment, but these may not be translated
into general practice if they are not clearly reported. Recruitment
of patients to trials may also be affected by the healthcare systems
in place; countries without public health services may recruit
participants who see a trial as their only means of treatment.
Their work highlights the need for trials to consider factors other
than the direct outcomes of a treatment, such as patient and
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practitioner experiences and attitudes and how clinical research
links to public health policy. An understanding of the mistakes of
the past may make it easier to develop scientiﬁc research which
addresses similar issues from the start. Rather than training
scientists in a limited way to understand the ethical and cultural
aspects of medical research, it would be more effective to bring in
existing expertise from humanities scholars.
Critical reﬂection. The ability to critically analyse the literature is
a skill developed at undergraduate level which remains important
throughout a scientiﬁc career. Research students are taught to
assimilate published research to inform their own experiments and
understand the context of their project. These critical analysis skills
are often not applied in other situations, such as to the meth-
odologies used during research. In partnership with the Leeds
University Business School, the iMBE allowed groups of its
researchers to enrol on a postgraduate course in Professional
Innovation Management. As well as discussing the common view
of innovation as the creation of new technologies, the course aimed
to provide researchers with the skills to be innovative in their
research methodologies. It involved practicing a range of critical
analysis and critical reﬂection techniques to consider inefﬁciencies
in their current work. The tools provided felt very unfamiliar at the
start of the course, and many students did not see how reﬂecting
on their feelings in a given situation within the lab would help
inform their work. Developing these skills in researchers more
widely would allow them to better consider other perspectives to
challenge their own perceptions, but they would still be constrained
by their area of expertise. Such skills are being introduced to the
next generation of scientists at undergraduate level, such as
through assessment of reﬂective journals during ﬁnal year project
work, but there are many established researchers who will not have
this experience. Encouraging the involvement of humanities
researchers trained in these skills to advise on laboratory research
methods may help provide a wider perspective.
One of the areas where a different perspective would be of great
beneﬁt to researchers in regenerative medicine would be to
improve understanding of patient expectations. As researchers,
we often aim to restore normal function in the damaged tissue; in
many cases patients primarily want relief from pain, as this can be
the most limiting factor in their daily lives. An example of this is
total hip replacements (THRs), where the device is designed to
restore normal function and different combinations of materials
may even allow the patient to take part in high-impact activities.
Since their development following World War II, hip prostheses
have undergone many developments in material, manufacture
and surgical procedure. There has also been a huge change in the
expectations of patients and surgeons around the outcomes of
these operations, discussed in detail by Anderson et al. (2007).
Initial expectations of pain relief have been replaced by a desire to
return to normal activities, as well as a shift towards younger
patients requiring longer lasting prosthesis and perhaps several
revision surgeries. The book also explores the changing nature of
information provided to patients, from leaﬂets written by
surgeons (covering the disease, procedure and hospital stay) to
those produced later with patient input or even entirely by
patients. This shift in style provides more information to the
patients on the risks, as well as the impact on many aspects of
their daily lives, information they may not discuss openly during
surgical consultations. This dialogue is still far removed from the
world of the laboratory researcher who may be developing the
materials or prostheses. The exposure to a range of views would
beneﬁt the researcher by providing different perspectives and
allow patient beneﬁt to be better addressed along the develop-
ment pathway. Depending on the research environment, there
may be direct contact with clinicians and patients during research
design and development. Within NHS research institutions, there
is a strong focus on patient and public involvement (PPI) with
research, from deciding which research themes to prioritise
through to study design, evaluation and reporting. Outside of
research in NHS institutions, this interaction may be limited to
the people who obtained funding, and is not always available to
postdoctoral researchers. Raising the awareness of medical history
texts exploring PPI may provide laboratory researchers with an
insight into the importance of considering how technologies may
affect the patient, far removed from the laboratory.
Ethics and culture. Considering the ethical implications of a
given scientiﬁc technique, treatment or clinical trial is another
area which would often beneﬁt from the perspective of someone
working outside the ﬁeld. Animal and human tissues are often
used in a laboratory setting for a wide range of applications, such
as the isolation of cells for use in basic research. For many
researchers this will represent the ﬁrst encounter with the real
world application of ethics and working to established regula-
tions. Without detailed knowledge of the ethical arguments for a
particular regulation, or involvement in the preparation of ethics
agreements for research, scientists may fail to grasp what the
regulations are designed to protect. One area of research in
regenerative medicine revolves around processing natural tissues
(such as skin or tendon) to remove the cells. This leaves a matrix
of proteins and biologically active molecules, which can be
recognised by the body. While the cells within a tissue are unique
to an individual, the rest of the tissue is highly similar between
different people and even different species. If the cells are
removed, the question can be raised as to whether the tissue still
belongs to a particular donor or animal–when is a pig not a pig?
While researchers may look upon the use of animal tissue as
necessary to maintain a supply of suitable graft material, there are
many situations in which this may not be appropriate. Patients
may have religious objections to donated tissue, whether the
source is animal or human, or it may only be problematic from a
particular animal. These viewpoints are important to consider
when designing the initial programme of research, to ensure that
it has the potential to form a useful therapy. Researchers may not
be equipped to answer questions like these, such as does the
perception of a treatment change when it is a lifesaving tech-
nology compared to one which only improves the quality of life?
These sorts of questions are also important in the regulation of
new technologies for human beneﬁt which use animal products.
From the early days using irradiated mouse feeder cells to pro-
duce skin grafts from human cells, to the use of animal derived
matrices, regulations have evolved to prevent cross-species dis-
ease transmission (Michael et al., 2006). Such regulations could
provide a glimpse into the practical implications of these ques-
tions, but relatively few within the laboratory consider the route
to market of their work during development.
At the fringes of current research, the biggest dreamers are
starting to investigate what most would consider science-ﬁction.
Advances and developments in areas such as cybernetics,
cryopreservation, regeneration and rejuvenation have the poten-
tial to change all aspects of society. It is our belief that the
implications of this research should be looked at pre-emptively
rather than in a reactionary manner. Indeed, such research is
being carried out already by numerous researchers in philosophy,
for example the ethical issues raised in Savulescu and Bostrom’s
edited collection, Human Enhancement (2009) or Jérôme
Goffette’s concept of ‘anthropotechnics’ (a distinction between
medical ‘repair’ and augmentation) (Goffette, 2015). To allow the
social, economic, and cultural implications of scientiﬁc advances
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to be discussed before they become a reality, research scientists
must actively engage with the wider academic community to
develop and advise on legal and ethical frameworks to cover
future developments. It may also provide insights into how new
technologies may be used or misused, the fears that could be
played upon in the public mind, and suggest new uses that the
developers have never considered. We would argue that the only
way for such a culture to develop is for regular dialogue between
disciplines, and that a regular forum for these discussions must be
established to overcome the problems encountered when every
new initiative in this area is forced to ‘reinvent the wheel’ of
science-humanities communication.
The cultural and ethical questions raised by new research ideas
require consideration and debate before a new treatment enters the
clinical setting. An example of this can be seen in the history for
the treatment of diabetes. For many years, insulin-dependent
diabetic patients would have received animal source insulin from
pigs, cows, horses or ﬁsh. Whilst this treatment worked well and
was responsible for saving many lives, impurities in the extracts
meant different batches of medicine did not show the same
effectiveness. The ﬁrst instance of genetic engineering was used to
create a synthetic version of human insulin in 1978, which came to
market in 1982 (Quianzon and Cheikh, 2012). Synthetic insulin
can be produced to a much higher standard of reproducibility and
is now the source for 70% of patients around the world. Using a
synthetic analogue of human insulin also means that the treatment
is suitable for those with ethical objections to the use of animal
products as medicine. This technique uses genetic modiﬁcation to
produce a lifesaving drug based on the human insulin molecule.
This case demonstrates not only the ethical considerations that can
face medical research but also how such considerations can be used
to drive research and development, leading to innovation with a
further reaching impact.
The use of animal models in research is another area of intense
ethical debate. Animals have been used for millennia to try and
develop our understanding of biological processes. Early work on
anatomy was often conducted using a range of animals, which led
to many misunderstandings and incorrect assumptions about
human anatomy. One of the most famous examples of this is in
the works of Claudius Galenus (A.D. 131–192). Galen mis-
represented the shape of the human heart, the location of the
kidneys, the shape of the liver and he stated that rete mirabile, at
the base of hoofed animal’s brains, was present in humans
(Malomo et al., 2006). Galen made these mistakes because he
relied on animal dissection, as human dissection was not only
taboo but illegal. Galen was revered and, since the taboo persisted,
many of his erroneous ideas were perpetuated and the ﬁeld of
anatomy advanced slowly until the sixteenth century. There are
now many animal models of human disease, which are used to
develop new treatments. The use of such models can provide
insight into disease progression or understanding of how a new
drug interacts with the body. Since the latter part of the 20th
century, there has been a drive to reduce the reliance on these
models in research, due in part to recognising the disparity
between results in animals and outcomes in human patients (van
der Worp et al., 2010). Such discrepancies may arise due to inter-
species variability in molecular processes, or differences in the
way a particular disease affects humans. In addition to scientiﬁc
limitations, there are many ethical objections to the use of
animals in research. Concerns over the animal welfare have led to
many strict guidelines on the care and handling of animals and
more rigorous study design to ensure that the minimum number
of animals are used to provide a conclusive research outcome.
In the UK, the NC3Rs (National Centre for Replacement,
Reﬁnement and Reduction of Animal Models in Research) was
set up to promote reduction and reﬁnement in the use of animal
models (NC3Rs, 2017). The ethical objections and inadequacies
of animal models are a driver of new research that is changing the
face of regenerative medicine and medical diagnostics. People
who choose to work in the ﬁeld of regenerative medicine have
widely accepted that at some point animal products, tissues or
models will be necessary to supplement our understanding. This
wide acceptance leaves very few people who are actively engaged
with this ﬁeld who can voice the opposite opinion; interaction
with people outside of the research setting not only provides
researchers with the impetus to critically evaluate what we are
doing and what we need to learn from any animal work. Working
to reduce the reliance on animal models for research has already
led to the emergence of new research areas. For example, the
development pathway for the growth of whole organs for
transplant has led to the development of small model tissues
that can be used in the creation of so-called “organ on a chip”
technologies (Bhise et al., 2014). Such technologies may
eventually offer a comprehensive alternative to animal models
of drug interaction.
Communication. One of the most daunting areas facing a sci-
entist is communicating the importance of their research. While
we may believe strongly in what we are doing, it can often be
difﬁcult to express this in a format which is understood by a non-
specialist. Grant awards often now require demonstration of
research impact and public engagement. Communication of
complex ideas is not only an important skill when applying for
funding, it is becoming more important than ever to commu-
nicate research to a wide, public audience. More than demon-
strating impact and dissemination of ﬁndings to public
stakeholders, it is important to inspire not only the next gen-
eration of scientists, but people of every age to engage more with
the advances in medical treatments that may 1 day be available to
them. The Royal Society has been organising public lectures for
general audiences for over 200 years. The Christmas lecture series
was founded in 1825, to bring complex scientiﬁc concepts to
young people, a tradition which continues successfully to this day.
Many researchers still do not take part in events which engage the
public about their research for a variety of reasons, often
including a perceived lack of relevant skills. Interaction with the
public can be daunting as it requires the scientist to leave the
comfort zone of their technical language and express complicated
concepts in a simple manner. Speciﬁc terminology may be
indecipherable to researchers outside of a speciﬁc ﬁeld, let alone
to a non-scientist. Persuading researchers to avoid acronyms or
that having to use a short phrase instead of a single scientiﬁc term
can be difﬁcult. Other terms may have different meanings in the
laboratory to in general use. One good example is the word
‘theory’–in a scientiﬁc context, a theory is an explanation whose
predictions have been veriﬁed by experiments or other evidence,
whereas in colloquial speech a theory is a conjecture or guess. The
most famous example of this is the theory of evolution, which is
supported by a huge body of scientiﬁc research and under-
standing, but is often dismissed, by its detractors, as ‘just a
theory’.
Breaking these language barriers can have beneﬁts for the
researcher, which many do not recognise until confronted with
the situation. Being able to explain your research in simple terms
requires you to have a greater understanding of your work and its
context. The beneﬁt of working with literary colleagues in this is
to ensure that the language does not become too simplistic as to
become a different type of incomprehensible. To demonstrate
this, Theo Sanderson challenged people to describe their job using
only the 1000 most common words using an online text editor
(Sanderson 2013). This was inspired by an issue of the xkcd
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webcomic (Munroe 2013), explaining the Saturn V rocket using
only these 1000 words (Fig. 1), demonstrating clearly that using
only common words does not necessarily lead to clear
explanations. Since the creation of an online text editor for the
challenge, hundreds of scientists have attempted to explain their
research with these limited terms, and some of the responses are
available on the website. While the challenge of translating your
work into these simplistic terms is a useful exercise in identifying
overly technical language, it is very restrictive and leads to equally
unhelpful explanations. Working closely with authors could help
scientists think about their language, without ‘dumbing down’.
Working closely with visual artists has the potential to convey
difﬁcult concepts without words at all. A technique developed to
demonstrate bacterial evolution for undergraduate teaching at
Harvard was later used in research to demonstrate the rapid
evolution of antibiotic resistance (Baym et al., 2016). The
associated video quickly caught the attention of the media and
presented a minor victory in science communication (Pesheva,
2016). If science researchers were supported in building long-
lasting partnerships with artists, such ‘viral’ successes might
become commonplace. Scientiﬁc communication should be used
to inspire and inform, and it is critical to ensure that the language
or expression used is not condescending. There are also many
opportunities to help create other artistic works inspired by
science, either through public or professional collaborations. This
enables researchers to display their scientiﬁc work, even if they do
not feel that they have the required skills. There is a growing
interest in these sorts of collaborations, with funding bodies such
as the Wellcome Trust creating funding opportunities. Encoura-
ging scientiﬁc researchers to engage with these schemes, which
may take time away from their experimental research, is key to
ensuring their success.
Funding. Scientiﬁc research is carried out within the constraints
of strict budgets and new research ideas are explored subject to
the acquisition of suitable funding. For many research councils,
there are speciﬁc research priorities which they are interested in
funding. Researchers must therefore clearly focus their research to
ﬁt within these themes, which can greatly restrict the areas of
exploration available to them. While there are large programme
grants which allow for more open research directions, these are
only available to those with well-established careers and pub-
lication records. The nature of this research landscape means
there is now minimal funding available for ‘blue sky’ research,
which may prevent serendipitous discovery as has been seen
many times in the past. Whilst regenerative medicine researchers
believe that their work will have huge beneﬁts for society and
patients a lack of understanding of healthcare economics and
community services means that this may not always be the case.
In many cases, translation of a new technology from a research
environment to the clinic fails, which may be inﬂuenced by a
variety of different factors. The problems of implementation and
adoption are numerous, but beyond the scope of this paper. The
authors recognise, however, that these issues are taken seriously
by health researchers (examples include Portela et al. (2015) and
Jones et al. (2014)).
An understanding of community support is also important; if
new regenerative therapies require a high level of assistance,
physiotherapy or monitoring by experts, the required support
structures may not be in place for the technology to be a success.
Input from those who understand how health economics,
community support and patient aftercare work before research
reached clinical trials could raise potential issues earlier in the
development pathway. While there are many researchers working
in these ﬁelds, they are often not involved in research until it
leaves the laboratory and is working towards clinical trials. This
means that signiﬁcant time, effort and resources may have been
invested in something which will not work in a practical setting.
Contact with patients is also important to understand whether a
particular technology or therapy would be practical in their daily
lives.
The way forward
To try and address some of the problems introduced throughout
this paper, it is increasingly apparent that we need better com-
munication and knowledge transfer across the whole spectrum of
research in regenerative medicine. We believe that closer rela-
tionships between regenerative medicine and the humanities
would enable researchers to better understand the historical
context, ethical implications and public perception of this rapidly
developing ﬁeld. This has the potential to inﬂuence research
decisions, improve communication between researchers, health-
care practitioners and the public and encourage a wider
engagement with the cutting edge of biomedical research.
Laboratory researchers in regenerative medicine face many
challenges not directly relating to their research. These can
include developing an understanding of the ethical or cultural
implications of their work, communication challenges or critical
reﬂection. Lack of exposure to other viewpoints may make it
difﬁcult for scientists to understand how their research may be
viewed in a negative light, as they are driving to make a positive
difference. In other cases, a lack of access to the clinical setting
may prevent researchers from developing technologies which can
be successfully translated into new treatments for patients.
Engaging with researchers outside of the scientiﬁc world who
Fig. 1 The dangers of oversimpliﬁcation of language when describing
scientiﬁc equipment. Partial reproduction of issue 1133 of the xkcd
webcomic (https://xkcd.com/1133/), which led to the creation of the Up-
Goer Five text editor (http://splasho.com/upgoer5/). Image reproduced
under the Creative Commons Attribution-NonCommercial 2.5 License, as
detailed on the author’s website (https://xkcd.com/license.html)
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have skills and understanding in these areas could be beneﬁcial
for research development and perception outside of the lab.
Whilst preparing this article and considering areas in which we
(as early career scientiﬁc researchers) felt underprepared, it
became clear to us that there were many existing experts in these
areas. For example, the Centre for History and Philosophy of
Science at the University of Leeds was within easy reach but
unknown to us until a late stage in writing. The biggest hurdle is
ensuring better transfer of knowledge and expertise between the
groups.
There are many possibilities which could help encourage and
normalised such collaborations. The scientiﬁc authors of this
paper found the Past, Present and Futures workshop to be a very
positive experience, which led to their desire to write this article.
Such discussions of what our goals as laboratory based regen-
erative medicine researchers and what the terms mean to scholars
outside this world provide an opportunity for reﬂection on our
aims and understanding. To encourage such interaction from a
wider range of scientists, it may be interesting to look at lectures
or seminars, presented concurrently by both scientists and
humanities scholars. Many departmental seminar series are well
attended by those within the school, and these may be a good
place to introduce wider concepts to the audience.
Engagement with the humanities has the potential to drive
academic development. New concepts are often explored in lit-
erature and popular culture before or at the point of new scientiﬁc
developments. A prime example of this is the impact that Star
Trek has had on our lives. Dr Martin Cooper, inventor of the ﬁrst
handheld mobile phone, credits the original series communicator
as his inspiration. Star Trek has also had a huge impact on
medical research goals such as the X-price to develop a handheld
medical diagnostic device akin to the tricorder. Current medical
developments such as 3D printing are ﬁnding their way into
popular culture; FRANKεN5Tε1N, a 2015 modern retelling of
Mary Shelley’s novel, has the monster 3D printed rather than
assembled from the graveyard.
To foster a more visible literary understanding of the regen-
erative medicine research, the ideas of writers in residence within
large research groups has considerable merit. Immersing a writer
in the world of research will allow them to bring an outside
perspective to the researchers, as well as spending time under-
standing how the laboratory functions. This would allow
opportunities to question scientiﬁc practices and see how time
and resources can affect the scientiﬁc process. Discussion of these
processes with someone from outside their professional sphere
could help scientists critically reﬂect on their work and help them
understand outside perspectives. For these sort of collaborations
to function, there would need to be input from the scientiﬁc
funding streams to include salary for the humanities researcher or
creative artist. This could be to cover a short-term secondment or
a longer term residence. A longer term style of collaboration may
also help scientists acclimatise to working closely with humanities
researchers from PhD students upwards, placing this as a normal
activity in their future careers. Depending on the speciﬁc colla-
boration, it would also allow scientists time to immerse them-
selves in the world outside the laboratory and gain further insight
into ethics, cultural or healthcare research. Collaborations such as
these could be designed to ensure impact for the research,
through better communication, production of cross-disciplinary
works or personal development of researchers. Such schemes
could encourage the production of new materials and exhibits to
start discussions around scientiﬁc advance and research.
While public engagement with research is now being driven
forward, partly due to the expectations of research councils, it has
a much wider potential. Involvement of ethicists and cultural
studies researchers could help move scientists away from the
simple attitude of ‘tell the public what you did with the money
they gave you’. This could be to engage the public in debates,
allowing their opinions and concerns to reach the scientists while
they conduct the research. Such debates can be of great value to
the researcher, forcing them to think about their research in less
technical language and solidifying their knowledge to respond to
questions from outside their limited scientiﬁc circle. One driver of
engagement with schoolchildren is to instil in them an interest in
science and to encourage the idea that it is not just for the geeks.
It is also useful to encourage them to think critically about the
media’s portrayal of scientiﬁc development and our own role in
allowing this portrayal–have we been doing enough to ensure that
our science does not seem aloof and suspicious? This interaction
at an early career stage may help equip the next generation of
principal investigators with the skills to consider the wider
implications of their research and give them the conﬁdence to
engage with non-scientists. Even if young researchers are not
currently developing their own research with a view to transla-
tion, knowledge of the skills and expertise available to them
outside of their ﬁeld could make an enormous difference when
they gain independence. Many junior researchers do not realise
the range of studies outside of science which can inform devel-
opment and translation.
Perhaps the most important reason to encourage these colla-
borations is to help make them a normality. Regenerative medi-
cine research should not be secluded, as it is carried out with the
end goal of providing beneﬁt to patients. Encouraging colla-
boration between those who research the cultural, social and
ethical effects of research and those who perform the research
would help drive research forward in a manner which is useful to
society.
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